Lung Cancers Completed Phase 2 Trials for Vinorelbine (DB00361)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01443078Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)Treatment
NCT01839032Oral Vinorelbine as Induction Chemotherapy Followed Concomitant ChemoradiotherapyTreatment
NCT00309998Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00057798Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before SurgeryTreatment
NCT00026156S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00008333Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerTreatment
NCT00005865Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00003587S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerTreatment